«DAKO

Below is an extended DAKO news listing. Click here to return to the DAKO main Biocorporate entry.

BioNews Results for DAKO:
Potential Biologic Markers Of Cholangiocarcinoma Medical News Today: Sep 28 2008 3:00PM Matching: dako
Equipment failure may have caused testing errors Report On Business: Sep 13 2008 9:28AM Matching: dako
N.L. cancer inquiry hears equipment failure could have caused botched tests Calibre Macro World: Sep 13 2008 8:50AM Matching: dako
Research and Markets: In 2007, the Estimated Cancer Biomarker Market Accounted for around 55% of Biomarker Rev SmartBrief: Sep 8 2008 6:59PM Matching: dako
A novel ex-vivo application of RNAi for neuroscience Bio Techniques: Sep 7 2008 11:18PM Matching: dako
Danish cancer diagnostics company Dako Group acquires Norwegian instruments developer InstrumeC TMC Net: Sep 3 2008 12:46PM Matching: dako
Danish cancer diagnostics company Dako Group acquires Norwegian instruments developer InstrumeC Macro World Investor: Sep 3 2008 10:07AM Matching: dako
Danish cancer diagnostics company Dako Group acquires Norwegian instruments developer InstrumeC Calibre Macro World: Sep 3 2008 9:57AM Matching: dako
Danish cancer diagnostics company Dako Group acquires Norwegian instruments developer InstrumeC Therapeutics Daily: Sep 3 2008 11:55AM Matching: dako
Dako, Bristol-Myers combine forces on theranostics Medical Device Link: Aug 27 2008 2:54PM Matching: dako
Biomarkers: The Future of Next-Generation Drug R&D Explored in this New Report Pharma Live: Aug 27 2008 7:51PM Matching: dako
Latest Most Up-to-Date Cancer Personalized Medicine Market Report Business Wire via Yahoo!: Jul 16 2008 8:22AM Matching: dako
Aggressive Type of Cancer Gets New Tests Wall Street Journal Online: Jul 9 2008 1:57AM Matching: dako

«DAKO

This page contained an extended DAKO news listing. Click here to return to the DAKO main Biocorporate entry.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.